Dr. Susan Taylor -- Pharmaceutical Payment Report

This page provides a comprehensive transparency report for Dr. Susan Taylor, a Infectious Disease physician based in City, MD. All payment data is sourced from the CMS Open Payments (Sunshine Act) database. Dr. Susan Taylor has received $177.38 in total pharmaceutical industry payments across 1 transactions from 1 pharmaceutical companies.

Physician Profile

The following profile information is sourced from the National Provider Identifier (NPI) registry and CMS Open Payments records.

  • Full Name: Dr. Susan Taylor
  • Medical Specialty: Infectious Disease
  • Practice Location: City, MD, Maryland
  • NPI Number: 1143501298
  • Transparency Score: 50/100
  • Payment Records Span: 2024-06-18 to 2024-06-18

Payment Summary

Dr. Susan Taylor has received a total of $177.38 in pharmaceutical industry payments across 1 recorded transactions in the CMS Open Payments database. The average payment amount is $177.38 per transaction.

  • Total Payments Received: $177.38
  • Number of Transactions: 1
  • Average Payment: $177.38
  • Transparency Score: 50/100 -- This score reflects the overall payment profile relative to peers in Infectious Disease. A higher score indicates fewer or more routine payments.
  • Number of Pharma Relationships: 1 pharmaceutical companies
  • Drugs/Devices Referenced: 1 distinct products

Payment Breakdown by Category

The following table shows how Dr. Susan Taylor's pharmaceutical payments break down by payment category. Understanding the mix of payment types provides important context about the nature of the doctor-pharma relationship.

Payment CategoryAmountDescription
Food & Beverage$177.38Meals and refreshments during sales visits, meetings, and events

The largest payment category for Dr. Susan Taylor is Food & Beverage, accounting for 100% ($177.38) of total pharmaceutical payments received. This is the most common type of pharmaceutical payment and typically involves meals provided during sales representative visits.

Pharmaceutical Company Relationships

The following pharmaceutical and medical device companies have made payments to Dr. Susan Taylor. Click on any company name to view their full physician payment profile and spending patterns.

CompanyTotal PaidTransactions
Merck & Co$177.381

Dr. Susan Taylor has a financial relationship with Merck & Co, receiving $177.38 in total. Having a single pharmaceutical company relationship means all payments come from one source, which may indicate a focused consulting or research relationship.

Drugs and Medical Devices Referenced in Payments

The following drugs and medical devices have been referenced in pharmaceutical payments to Dr. Susan Taylor. These references indicate that the payment was related to the marketing, consulting, or clinical use of these products.

  • Ocrevus -- Referenced in payment records from pharmaceutical companies to Dr. Susan Taylor

The presence of a drug or device in a payment record means the pharmaceutical company associated the payment with that product. This is common for consulting fees related to a specific medication, speaking engagements about a product, or research involving a particular drug or device.

AI Transparency Analysis

The following analysis was generated by artificial intelligence based on Dr. Susan Taylor's payment history, specialty peer comparisons, and payment pattern analysis. This analysis is not medical or legal advice.

Susan Taylor has received $177.38 across 1 pharmaceutical payments as a Infectious Disease physician in City, MD. Top paying companies include Merck & Co ($177.38). Dr. Susan Taylor received a single payment of $177 in 2024, which is the only payment recorded in her profile. The payment was for meals and came from Merck & Co, the only company involved in her payment history.

Patient Guidance: Questions to Ask Your Doctor

If Dr. Susan Taylor is your physician, here is practical guidance on how to understand and discuss pharmaceutical industry relationships:

Consumers should be aware that Dr. Taylor has received a single payment for meals from Merck & Co, and there is no additional payment information available. Always feel free to ask your doctor directly about their pharmaceutical relationships.

Peer Comparison: How Dr. Susan Taylor Compares to Other Infectious Disease Physicians

Compared to peers in Infectious Disease, Dr. Taylor's payment profile is relatively transparent but lacks diversity in payment sources.

Recent Payment Records

The following table shows the most recent pharmaceutical industry payments recorded for Dr. Susan Taylor in the CMS Open Payments database. Click on any payment to view the full report.

CompanyAmountTypeDrug/DeviceDateConflict Level
Merck & Co$177.38mealsOcrevus2024-06-18Not Assessed

Frequently Asked Questions About Dr. Susan Taylor's Pharma Payments

Below are common questions patients ask about physician pharmaceutical payment data.

How much pharma money has Susan Taylor received?

Susan Taylor has received a total of $177.38 across 1 payments from pharmaceutical companies. This data is publicly reported under the CMS Open Payments (Sunshine Act) program.

Is Susan Taylor taking too much pharma money?

Susan Taylor has received $177.38 in pharmaceutical payments. Whether this is "too much" depends on the physician's specialty (Infectious Disease), the types of payments, and how they compare to peers. The largest payment category is meals ($177.38). Payment does not imply wrongdoing, but patients should be aware and can ask their doctor directly.

What pharma companies pay Susan Taylor?

The top pharmaceutical companies paying Susan Taylor are: Merck & Co ($177.38). These payments cover various categories including consulting, meals, speaking fees, and research grants.

What kinds of payments does Susan Taylor receive?

Susan Taylor's payments by type: meals: $177.38. Food and beverage is the most common payment type across all physicians.

Should I switch doctors because of pharma payments?

Pharma payments alone are not typically reason to switch doctors. Many payments are routine (like meals at educational events) and do not indicate compromised care. Focus on: (1) whether your doctor explains treatment options clearly, (2) whether generic alternatives are discussed, (3) the overall pattern of payments, not individual transactions. If you have concerns, ask your doctor directly.

How do Susan Taylor's payments compare to other Infectious Disease doctors?

To compare, look at the total amount ($177.38), number of payments (1), and the types of payments received. Infectious Disease physicians may receive different payment amounts depending on subspecialty, geographic location, and academic affiliation. Use CMS Open Payments data to compare across the specialty.

How can I verify Susan Taylor's payment data?

You can verify this data directly through the CMS Open Payments database at openpaymentsdata.cms.gov. Search by physician name or NPI number (1143501298). All data is reported by pharmaceutical companies and verified by CMS. DoctorPharmaData aggregates this public data for easier access.

Do pharma payments affect prescribing quality?

Research published in JAMA Internal Medicine and other peer-reviewed journals shows a statistical association between pharmaceutical payments and prescribing patterns. However, correlation does not equal causation. Many physician-industry interactions are legitimate (research, education, advisory boards). The Sunshine Act was created to promote transparency so patients can make informed decisions.

What stands out about Susan Taylor's pharma payment profile?

Dr. Taylor has a 100% concentration of payments from a single company, Merck & Co. Susan Taylor has received $177.38 in total pharma payments.

How does Susan Taylor compare to peers in Infectious Disease?

Compared to peers in Infectious Disease, Dr. Taylor's payment profile is relatively transparent but lacks diversity in payment sources.

Are Susan Taylor's pharma relationships typical for Infectious Disease?

She received a single payment of $177 in 2024, indicating a lack of diversity in her payment sources.

What should patients of Susan Taylor know about these payments?

Consumers should be aware that Dr. Taylor has received a single payment for meals from Merck & Co, and there is no additional payment information available.

What patterns are visible in Susan Taylor's payment history?

The payment type is meals, which is the only type of payment recorded in her profile.

Understanding This Doctor Payment Report

This transparency report for Dr. Susan Taylor is based on data from the CMS Open Payments database, which is maintained by the Centers for Medicare and Medicaid Services under the Physician Payments Sunshine Act. Here are important things to understand:

  • Payment does not imply wrongdoing. Many pharmaceutical payments represent legitimate professional activities such as consulting on drug development, speaking at medical education events, and conducting clinical research.
  • Context matters. A large payment for conducting a clinical trial has very different implications than a large payment for promotional speaking. The payment breakdown by category above provides this context.
  • Peer comparison is important. Whether a payment amount is unusual depends heavily on the physician's specialty, geographic location, and career stage. Infectious Disease physicians may have very different payment norms than physicians in other fields.
  • Data may be incomplete. The CMS Open Payments database captures payments from pharmaceutical and medical device manufacturers. It does not include payments from other sources, such as hospitals, insurance companies, or government agencies.
  • Reporting thresholds apply. Small payments below certain thresholds may not be individually reported. The totals reflect payments above reporting minimums set by CMS regulations.

About the Physician Payments Sunshine Act

The Physician Payments Sunshine Act, enacted as Section 6002 of the Affordable Care Act in 2010, requires pharmaceutical and medical device companies to report payments and other transfers of value to physicians and teaching hospitals to CMS. This law was designed to increase transparency in the financial relationships between the healthcare industry and medical providers.

Under this law, Dr. Susan Taylor's pharmaceutical payments are publicly disclosed. The types of reportable transactions include consulting fees, compensated speaking or educational activities, honoraria, gifts, entertainment, food and beverages, travel and lodging, education or conference attendance, research grants, charitable contributions, royalties or licenses, current or prospective ownership interests, and direct compensation for services other than consulting.

The Open Payments data for Dr. Susan Taylor and all other physicians can be accessed at the official CMS Open Payments website.

Other Infectious Disease Physicians

Compare Dr. Susan Taylor's pharmaceutical payments with other Infectious Disease physicians ranked by total pharma payments received.

PhysicianStateTotal Payments
Gregory EvansOH$279,484.85
Rachel ParkerPA$279,123.18
Lisa GarciaPA$209,026.24
Benjamin CookAZ$194,254.81
Karen HarrisPA$180,688.94
Robert JohnsonOH$107,730.34
Rachel ParkerGA$101,872.63
Robert JohnsonMO$62,810.39
Rebecca AdamsTN$43,269.78
Daniel WhiteLA$40,640.49

Top Doctors in Maryland

These physicians in Maryland have received the highest pharmaceutical payments. See how Dr. Susan Taylor compares to peers in the same state.

PhysicianSpecialtyTotal Payments
Mark PerezDermatology$252,123.85
Daniel WhiteOncology$190,897.87
Stephanie KingPsychiatry$173,577.30
Benjamin CookPulmonology$166,897.94
Kevin HillOphthalmology$146,566.41
Joseph CarterOncology$119,514.27
Ashley NelsonInternal Medicine$115,788.40
Robert JohnsonDermatology$93,936.12
Susan TaylorOphthalmology$90,746.62
Jennifer PatelNeurology$76,714.13

Related Resources

Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.